Cargando…

Correlation between immune-related adverse events and long-term outcomes in pembrolizumab-treated patients with unresectable hepatocellular carcinoma: A retrospective study

BACKGROUND: Although immune checkpoint inhibitor (ICI) therapy has improved the prognosis of unresectable hepatocellular carcinoma (HCC), it has also resulted in unique immune-related adverse events (irAEs). The relationship between irAE and treatment outcomes in ICI-treated unresectable HCC patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jiang-Min, Xiong, Hui-Fang, Chen, Xiao-Ping, Zhang, Zhi-Wei, Zhu, Li-Ping, Wu, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134210/ https://www.ncbi.nlm.nih.gov/pubmed/37123056 http://dx.doi.org/10.4251/wjgo.v15.i4.689

Ejemplares similares

Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study
por: Wang, Zhe-Xuan, et al.
Publicado: (2020)

Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Novel endoscopic papillectomy for reducing postoperative adverse events (with videos)
por: Jiang, Lei, et al.
Publicado: (2020)

Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States
por: Li, Daneng, et al.
Publicado: (2023)

Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
por: Teyateeti, Ajalaya, et al.
Publicado: (2021)

Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma
por: Wang, Yan-Yu, et al.
Publicado: (2023)

Retrospective analysis of surgically treated pT4b gastric cancer with pancreatic head invasion
por: Jin, Peng, et al.
Publicado: (2021)

Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma
por: De Wilde, Nika, et al.
Publicado: (2022)

Pediatric endoscopy across multiple clinical settings: Efficiency and adverse events
por: Crawford, Erin, et al.
Publicado: (2022)

Adverse events in critical care: Search and active detection through the Trigger Tool
por: Molina, Francisco J, et al.
Publicado: (2018)

Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study
por: Shimose, Shigeo, et al.
Publicado: (2020)

Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma
por: Liu, Zhi-Peng, et al.
Publicado: (2022)

Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria
por: Gao, Long, et al.
Publicado: (2023)

Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability
por: Shi, Hao-Jun, et al.
Publicado: (2016)

Safety and efficacy of metallic stent for unresectable distal malignant biliary obstruction in elderly patients
por: Sakai, Yuji, et al.
Publicado: (2018)

Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
por: Yamada, Kentaro, et al.
Publicado: (2021)

Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
por: Yang, Dan-Hong, et al.
Publicado: (2021)

Evaluating the risk of adverse events with interventional endoscopic retrograde cholangiopancreatography and endoscopic ultrasound procedures in cirrhotic patients
por: Yoo, Timothy, et al.
Publicado: (2019)

Nomograms for pre- and postoperative prediction of long-term survival among proximal gastric cancer patients: A large-scale, single-center retrospective study
por: Chen, Qi-Yue, et al.
Publicado: (2019)

Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
por: Lew, Daniel, et al.
Publicado: (2017)

Postoperative adverse cardiac events in acute myocardial infarction with high thrombus load and best time for stent implantation
por: Zhuo, Ming-Feng, et al.
Publicado: (2022)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma
por: Wang, Jian-Ping, et al.
Publicado: (2020)

Racial disparities in immune-related adverse events of immune checkpoint inhibitors and association with survival based on clinical and biochemical responses
por: Peravali, Monica, et al.
Publicado: (2021)

Risk factors related to postoperative recurrence of dermatofibrosarcoma protuberans: A retrospective study and literature review
por: Xiong, Jian-Xia, et al.
Publicado: (2021)

Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus
por: Zhang, Zi-Han, et al.
Publicado: (2017)

Prospective single-center feasible study of innovative autorelease bile duct supporter to delay adverse events after endoscopic papillectomy
por: Liu, Sheng-Zhen, et al.
Publicado: (2022)

Risk factors for long-term prognosis of hepatocellular carcinoma patients after anatomic hepatectomy
por: Tian, Ya-Li, et al.
Publicado: (2020)

High serum lactate dehydrogenase and dyspnea: Positive predictors of adverse outcome in critical COVID-19 patients in Yichang
por: Lv, Xiao-Ting, et al.
Publicado: (2020)

Impact of body mass index in elderly patients treated with laparoscopic liver resection for hepatocellular carcinoma
por: Conticchio, Maria, et al.
Publicado: (2023)

Prevention and management of adverse events following COVID-19 vaccination using traditional Korean medicine: An online survey of public health doctors
por: Kang, Byungsoo, et al.
Publicado: (2022)

Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study
por: Appel-da-Silva, Marcelo Campos, et al.
Publicado: (2016)

Factors influencing the short-term and long-term survival of hepatocellular carcinoma patients with portal vein tumor thrombosis who underwent chemoembolization
por: Chen, Ke-Li, et al.
Publicado: (2021)

Clearance of the liver remnant predicts short-term outcome in patients undergoing resection of hepatocellular carcinoma
por: Miki, Atsushi, et al.
Publicado: (2022)

Correlation of abnormal histology with endoscopic findings among mycophenolate mofetil treated patients
por: Izower, Mitchell A, et al.
Publicado: (2017)

Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection
por: Sakamoto, Yuzuru, et al.
Publicado: (2022)

Continuous renal replacement therapy with oXiris(®) in patients with hematologically malignant septic shock: A retrospective study
por: Wang, Juan, et al.
Publicado: (2023)

Prediction of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm based on computed tomography radiomics
por: Liu, Peng, et al.
Publicado: (2021)

Cancer Chemotherapy-Induced Oral Adverse Events: Oral Dysesthesia and Toothache - A Retrospective Study
por: Hino, Shunsuke, et al.
Publicado: (2021)

Prognostic predictors in patients with sepsis after gastrointestinal tumor surgery: A retrospective study
por: Chen, Ren-Xiong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e1kpupub7oaneq8rmiml09uv75